| Business Segment Information |
Note 8 Business Segment Information
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended August 2, 2025 |
|
|
|
|
|
|
|
|
|
|
|
|
(In thousands) |
Journeys
Group |
|
Schuh
Group |
|
Johnston
& Murphy
Group |
|
Genesco Brands Group |
|
Corporate
& Other |
|
Consolidated |
|
Sales |
$ |
318,189 |
|
$ |
126,595 |
|
$ |
68,789 |
|
$ |
32,392 |
|
$ |
— |
|
$ |
545,965 |
|
Intercompany sales elimination |
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
Net sales to external customers(1) |
|
318,189 |
|
|
126,595 |
|
|
68,789 |
|
|
32,392 |
|
|
— |
|
|
545,965 |
|
Cost of sales |
|
162,761 |
|
|
77,412 |
|
|
31,631 |
|
|
24,212 |
|
|
— |
|
|
296,016 |
|
Gross margin |
|
155,428 |
|
|
49,183 |
|
|
37,158 |
|
|
8,180 |
|
|
— |
|
|
249,949 |
|
Selling and administrative expenses |
|
160,427 |
|
|
49,194 |
|
|
38,940 |
|
|
7,527 |
|
|
8,177 |
|
|
264,265 |
|
Segment operating income (loss) |
|
(4,999 |
) |
|
(11 |
) |
|
(1,782 |
) |
|
653 |
|
|
(8,177 |
) |
|
(14,316 |
) |
Asset impairments and other(2) |
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
124 |
|
|
124 |
|
Operating income (loss) |
|
(4,999 |
) |
|
(11 |
) |
|
(1,782 |
) |
|
653 |
|
|
(8,301 |
) |
|
(14,440 |
) |
Other components of net periodic benefit cost |
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
148 |
|
|
148 |
|
Interest expense, net |
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
1,459 |
|
|
1,459 |
|
Earnings (loss) from continuing operations before income taxes |
$ |
(4,999 |
) |
$ |
(11 |
) |
$ |
(1,782 |
) |
$ |
653 |
|
$ |
(9,908 |
) |
$ |
(16,047 |
) |
Total assets (3) |
$ |
766,666 |
|
$ |
220,416 |
|
$ |
196,781 |
|
$ |
69,603 |
|
$ |
168,459 |
|
$ |
1,421,925 |
|
Depreciation and amortization |
|
8,334 |
|
|
2,129 |
|
|
1,692 |
|
|
346 |
|
|
973 |
|
|
13,474 |
|
Capital expenditures |
|
7,697 |
|
|
2,345 |
|
|
4,367 |
|
|
64 |
|
|
209 |
|
|
14,682 |
|
(1) Net sales in North America and in the U.K., which includes the ROI, accounted for 77% and 23%, respectively, of our net sales in the second quarter of Fiscal 2026. (2) Asset impairments and other includes a $0.1 million charge for severance. (3) Of our $713.8 million of long-lived assets as of August 2, 2025, $95.3 million and $16.1 million relate to long-lived assets in the U.K. and Canada, respectively. Note 8 Business Segment Information, Continued
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended August 3, 2024 |
|
|
|
|
|
|
|
|
|
|
|
|
(In thousands) |
Journeys
Group |
|
Schuh
Group |
|
Johnston
& Murphy
Group |
|
Genesco Brands Group |
|
Corporate
& Other |
|
Consolidated |
|
Sales |
$ |
298,846 |
|
$ |
124,561 |
|
$ |
71,037 |
|
$ |
30,755 |
|
$ |
— |
|
$ |
525,199 |
|
Intercompany sales elimination |
|
— |
|
|
— |
|
|
— |
|
|
(11 |
) |
|
— |
|
|
(11 |
) |
Net sales to external customers(1) |
|
298,846 |
|
|
124,561 |
|
|
71,037 |
|
|
30,744 |
|
|
— |
|
|
525,188 |
|
Cost of sales |
|
153,617 |
|
|
72,131 |
|
|
33,769 |
|
|
20,032 |
|
|
— |
|
|
279,549 |
|
Gross margin |
|
145,229 |
|
|
52,430 |
|
|
37,268 |
|
|
10,712 |
|
|
— |
|
|
245,639 |
|
Selling and administrative expenses |
|
156,380 |
|
|
45,091 |
|
|
37,671 |
|
|
8,040 |
|
|
7,953 |
|
|
255,135 |
|
Segment operating income (loss) |
|
(11,151 |
) |
|
7,339 |
|
|
(403 |
) |
|
2,672 |
|
|
(7,953 |
) |
|
(9,496 |
) |
Asset impairments and other (2) |
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
778 |
|
|
778 |
|
Operating income (loss) |
|
(11,151 |
) |
|
7,339 |
|
|
(403 |
) |
|
2,672 |
|
|
(8,731 |
) |
|
(10,274 |
) |
Other components of net periodic benefit cost |
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
86 |
|
|
86 |
|
Interest expense, net |
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
1,345 |
|
|
1,345 |
|
Earnings (loss) from continuing operations before income taxes |
$ |
(11,151 |
) |
$ |
7,339 |
|
$ |
(403 |
) |
$ |
2,672 |
|
$ |
(10,162 |
) |
$ |
(11,705 |
) |
Total assets (3) |
$ |
668,528 |
|
$ |
205,488 |
|
$ |
157,936 |
|
$ |
80,954 |
|
$ |
270,845 |
|
$ |
1,383,751 |
|
Depreciation and amortization |
|
8,540 |
|
|
1,849 |
|
|
1,394 |
|
|
331 |
|
|
1,055 |
|
|
13,169 |
|
Capital expenditures |
|
4,313 |
|
|
1,764 |
|
|
1,461 |
|
|
304 |
|
|
55 |
|
|
7,897 |
|
(1) Net sales in North America and in the U.K., which includes the ROI, accounted for 76% and 24%, respectively, of our net sales for the second quarter of Fiscal 2025. (2) Asset impairments and other includes a $0.1 million charge for asset impairments in Journeys Group and $0.7 million for severance. (3) Of our $631.8 million of long-lived assets as of August 3, 2024, $92.1 million and $11.0 million relate to long-lived assets in the U.K. and Canada, respectively. Note 8 Business Segment Information, Continued
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Six Months Ended August 2, 2025 |
|
|
|
|
|
|
|
|
|
|
|
|
(In thousands)
|
Journeys
Group |
|
Schuh
Group |
|
Johnston
& Murphy
Group |
|
Genesco Brands Group |
|
Corporate
& Other |
|
Consolidated |
|
Sales |
$ |
590,823 |
|
$ |
222,510 |
|
$ |
145,628 |
|
$ |
60,977 |
|
$ |
— |
|
$ |
1,019,938 |
|
Intercompany sales elimination |
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
Net sales to external customers(1) |
|
590,823 |
|
|
222,510 |
|
|
145,628 |
|
|
60,977 |
|
|
— |
|
|
1,019,938 |
|
Cost of sales |
|
302,276 |
|
|
135,150 |
|
|
67,333 |
|
|
44,049 |
|
|
— |
|
|
548,808 |
|
Gross margin |
|
288,547 |
|
|
87,360 |
|
|
78,295 |
|
|
16,928 |
|
|
— |
|
|
471,130 |
|
Selling and administrative expenses |
|
308,829 |
|
|
93,502 |
|
|
79,577 |
|
|
15,577 |
|
|
15,815 |
|
|
513,300 |
|
Segment operating income (loss) |
|
(20,282 |
) |
|
(6,142 |
) |
|
(1,282 |
) |
|
1,351 |
|
|
(15,815 |
) |
|
(42,170 |
) |
Asset impairments and other(2) |
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
415 |
|
|
415 |
|
Operating income (loss) |
|
(20,282 |
) |
|
(6,142 |
) |
|
(1,282 |
) |
|
1,351 |
|
|
(16,230 |
) |
|
(42,585 |
) |
Other components of net periodic benefit cost |
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
328 |
|
|
328 |
|
Interest expense, net |
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
2,798 |
|
|
2,798 |
|
Earnings (loss) from continuing
operations before income taxes |
$ |
(20,282 |
) |
$ |
(6,142 |
) |
$ |
(1,282 |
) |
$ |
1,351 |
|
$ |
(19,356 |
) |
$ |
(45,711 |
) |
Depreciation and amortization |
$ |
16,583 |
|
$ |
4,053 |
|
$ |
3,480 |
|
$ |
688 |
|
$ |
2,063 |
|
$ |
26,867 |
|
Capital expenditures |
|
18,102 |
|
|
5,974 |
|
|
9,008 |
|
|
140 |
|
|
356 |
|
|
33,580 |
|
(1) Net sales in North America and in the U.K., which includes the ROI, accounted for 78% and 22%, respectively, of our net sales for the first six months of Fiscal 2026. (2) Asset impairments and other includes a $0.4 million charge for severance. Note 8 Business Segment Information, Continued
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Six Months Ended August 3, 2024 |
|
|
|
|
|
|
|
|
|
|
|
|
(In thousands)
|
Journeys
Group |
|
Schuh
Group |
|
Johnston
& Murphy
Group |
|
Genesco Brands Group |
|
Corporate
& Other |
|
Consolidated |
|
Sales |
$ |
558,291 |
|
$ |
216,910 |
|
$ |
150,244 |
|
$ |
55,354 |
|
$ |
— |
|
$ |
980,799 |
|
Intercompany sales elimination(1) |
|
— |
|
|
— |
|
|
— |
|
|
1,986 |
|
|
— |
|
|
1,986 |
|
Net sales to external customers(2) |
|
558,291 |
|
|
216,910 |
|
|
150,244 |
|
|
57,340 |
|
|
— |
|
$ |
982,785 |
|
Cost of sales |
|
285,418 |
|
|
126,300 |
|
|
70,382 |
|
|
38,765 |
|
|
— |
|
|
520,865 |
|
Gross margin |
|
272,873 |
|
|
90,610 |
|
|
79,862 |
|
|
18,575 |
|
|
— |
|
|
461,920 |
|
Selling and administrative expenses |
|
302,846 |
|
|
89,167 |
|
|
77,910 |
|
|
16,889 |
|
|
16,154 |
|
|
502,966 |
|
Segment operating income (loss) |
|
(29,973 |
) |
|
1,443 |
|
|
1,952 |
|
|
1,686 |
|
|
(16,154 |
) |
|
(41,046 |
) |
Asset impairments and other(3) |
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
1,356 |
|
|
1,356 |
|
Operating income (loss) |
|
(29,973 |
) |
|
1,443 |
|
|
1,952 |
|
|
1,686 |
|
|
(17,510 |
) |
|
(42,402 |
) |
Other components of net periodic benefit cost |
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
195 |
|
|
195 |
|
Interest expense |
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
2,235 |
|
|
2,235 |
|
Earnings (loss) from continuing
operations before income taxes |
$ |
(29,973 |
) |
$ |
1,443 |
|
$ |
1,952 |
|
$ |
1,686 |
|
$ |
(19,940 |
) |
$ |
(44,832 |
) |
Depreciation and amortization |
$ |
17,160 |
|
$ |
3,718 |
|
$ |
2,778 |
|
$ |
645 |
|
$ |
2,105 |
|
$ |
26,406 |
|
Capital expenditures |
|
7,804 |
|
|
2,497 |
|
|
3,176 |
|
|
535 |
|
|
262 |
|
|
14,274 |
|
(1) Intercompany sales for the first six months of Fiscal 2025 reflect net intercompany returns. (2) Net sales in North America and in the U.K., which includes the ROI, accounted for 78% and 22% respectively, of our net sales for the first six months of Fiscal 2025. (3) Asset impairments and other includes a $0.4 million charge for asset impairments in Journeys Group and $1.0 million for severance. |